Recalls / Active ingredient / Romosozumab
Romosozumab
1 FDA drug recall involving the active ingredient “Romosozumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-04-21 | Class II | EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Am | Mckesson Medical-Surgical Inc. Corporate Office |